These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21309905)
1. The role of federal preemption in injury prevention litigation. Vernick JS J Law Med Ethics; 2011 Mar; 39 Suppl 1():85-8. PubMed ID: 21309905 [No Abstract] [Full Text] [Related]
2. Tort litigation and federal regulation of medical devices. Piwinski S; Fitzpatrick S JAMA; 2008 Oct; 300(16):1881-2; author reply 1882. PubMed ID: 18940973 [No Abstract] [Full Text] [Related]
3. Good law from tragic facts--Congress, the FDA, and preemption. Annas GJ N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383 [No Abstract] [Full Text] [Related]
4. The medical device safety act of 2009: clarifying preemption. Turcott RG; Ashley EA Am J Ther; 2009; 16(6):471-4. PubMed ID: 19940607 [No Abstract] [Full Text] [Related]
5. The FDA, preemption, and the Supreme Court. Glantz LH; Annas GJ N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601 [No Abstract] [Full Text] [Related]
6. School-based policies: safety and injury liability. Bogden JF; Thomas GA; Barrios LC J Law Med Ethics; 2004; 32(4 Suppl):56-8. PubMed ID: 15807327 [No Abstract] [Full Text] [Related]
7. The deregulatory effects of preempting tort litigation: FDA regulation of medical devices. Gostin LO JAMA; 2008 May; 299(19):2313-6. PubMed ID: 18492972 [No Abstract] [Full Text] [Related]
8. Injured consumers and the FDA. Should federal preemption protect medical device manufacturers under a quasi-governmental immunity? Truitt BI J Leg Med; 1994 Mar; 15(1):155-84. PubMed ID: 8201276 [No Abstract] [Full Text] [Related]
9. The Supreme Court, preemption, and malpractice liability. Kesselheim AS; Studdert DM N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672 [No Abstract] [Full Text] [Related]
11. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix. Smirniotopoulos A Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960 [TBL] [Abstract][Full Text] [Related]
12. Law & psychiatry: SSRIs, suicide, and liability for failure to warn of medication risks. Appelbaum PS Psychiatr Serv; 2011 Apr; 62(4):347-9. PubMed ID: 21459983 [TBL] [Abstract][Full Text] [Related]
13. Reducing the risk of injury liability. Vaccaro PL; Bryant M Provider; 1995 Aug; 21(8):75-6. PubMed ID: 10144820 [No Abstract] [Full Text] [Related]
14. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion. Surprenant JA Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554 [TBL] [Abstract][Full Text] [Related]
15. The impact of Wyeth v. Levine on FDA regulation of prescription drugs. Ausness RC Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542 [TBL] [Abstract][Full Text] [Related]
17. Pharma industry's bitter pill ... could be impetus for devicemaker legislation, too. Blesch G Mod Healthc; 2009 Mar; 39(10):11. PubMed ID: 19610180 [No Abstract] [Full Text] [Related]
18. Toward a more perfect union: a federal cause of action for physician aid-in-dying. Robichaud TD Univ Mich J Law Reform; 1994; 27(2):521-64. PubMed ID: 11656405 [No Abstract] [Full Text] [Related]
19. Why the Supreme Court race is important. Schulte DJ Mich Med; 2012; 111(5):4. PubMed ID: 23167039 [No Abstract] [Full Text] [Related]
20. Court tells jury to ignore human subject protection regulations. Maloney DM Hum Res Rep; 1995 Mar; 10(3):4-5. PubMed ID: 11654195 [No Abstract] [Full Text] [Related] [Next] [New Search]